| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.25 | 4e-09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.041 | 0.3 |